** Medical device maker Adaptive Biotechnologies Corp's ADPT.O shares rise as much as 34.5% to over a year high of $9.9
** Stock is set for its best day since its IPO in 2019, if gains hold
** Late on Thursday, ADPT posted 25% rise in Q1 revenue to $52.44 million, beating analysts' estimates of $42.68 million
** Co reported Q1 net loss of $29.8 million, compared to $47.5 million for the same period in 2024
** Co reported cash, cash equivalents and marketable securities of $232.8 million as of March 31, 2025
** Co expects full year total company cash burn to be between $50 million and $60 million, from the previous range between $60 million and $70 million
** As of last close, ADPT has fallen 62.1% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.